NS1619 is a well-established BK channel activating compound29, but since we employed it for the first time in a mouse pneumonia model, it was important to confirm that the observed protective effects stem, indeed, from BK channel activation and not potential off-target effects. This evidence concerns the gene KCNMA1 and pneumonia.